{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:02:51Z","timestamp":1791907371326,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008096","name":"Virbac","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Giardia duodenalis<\/jats:italic> is a prevalent gastrointestinal parasite in dogs, causing diarrhea, vomiting, and weight loss. Metronidazole is a common treatment for this infection. This study aimed to evaluate the efficacy, safety, and acceptance of a flavored liquid metronidazole oral suspension in treating <jats:italic>G. duodenalis<\/jats:italic> in naturally infected dogs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A double-masked, vehicle-controlled, randomized, multi-center clinical field trial was conducted. Client-owned dogs with confirmed <jats:italic>G. duodenalis<\/jats:italic> infections were enrolled and randomized into AYRADIA-treated and control groups. The AYRADIA group received the metronidazole suspension at 0.2\u00a0ml\/kg twice daily for 5\u00a0days, while the control group received a flavored vehicle suspension without metronidazole. Fecal samples were collected before and after treatment to assess <jats:italic>G. duodenalis<\/jats:italic> cyst counts. Clinical examinations and owner assessments were also performed to evaluate safety and treatment acceptance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study enrolled 180 dogs, with 129 included in the efficacy analysis. AYRADIA treatment resulted in a 99.92% reduction in <jats:italic>G. duodenalis<\/jats:italic> cyst counts, significantly higher than the reduction in the control group. Adverse events were similar between both groups (10%), mainly consisting of diarrhea and vomiting. The treatment was readily accepted by 99% of dogs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>AYRADIA, administered at 0.2\u00a0ml\/kg twice daily for 5\u00a0days, is highly effective in treating <jats:italic>G. duodenalis<\/jats:italic> infections in dogs. The treatment demonstrated a positive safety profile and excellent acceptance. This flavored oral suspension offers a valuable and convenient option for veterinarians managing giardiasis in dogs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06797-w","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:39:47Z","timestamp":1747039187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of giardiasis in dogs: field clinical study to confirm the efficacy, safety, and acceptance of a metronidazole-based flavored oral suspension"],"prefix":"10.1186","volume":"18","author":[{"given":"Sloane","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Briantais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Von Simson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonore","family":"De Meyrignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Poincelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Rigaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"6797_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vetpar.2012.12.049","volume":"195","author":"AS Mohamed","year":"2013","unstructured":"Mohamed AS, Glickman LT, Camp JW, Lund E, Moore GE. Prevalence and risk factors for Giardia spp. infection in a large national sample of pet dogs visiting veterinary hospitals in the United States (2003\u20132009). Vet Parasitol. 2013;195:35\u201341.","journal-title":"Vet Parasitol"},{"key":"6797_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.vetpar.2010.06.015","volume":"173","author":"C Epe","year":"2010","unstructured":"Epe C, Rehkter G, Schnieder T, Lorentzen L, Kreienbrock L. Giardia in symptomatic dogs and cats in Europe\u2014Results of a European. Vet Parasitol. 2010;173:32\u20138.","journal-title":"Vet Parasitol"},{"key":"6797_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.vetpar.2014.12.011","volume":"207","author":"M Bouzid","year":"2015","unstructured":"Bouzid M, Halai K, Jeffreys D, Hunter PR. The prevalence of Giardia infection in dogs and cats, a systematic review and meta-analysis of prevalence studies from stool samples. Vet Parasitol. 2015;207:181\u2013202.","journal-title":"Vet Parasitol"},{"key":"6797_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.pt.2010.02.005","volume":"26","author":"LR Ballweber","year":"2010","unstructured":"Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. 2010;26:180\u20139.","journal-title":"Trends Parasitol"},{"key":"6797_CR5","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/vms3.1270","volume":"9","author":"M Mateo","year":"2023","unstructured":"Mateo M, Montoya A, Bailo B, K\u00f6ster PC, Dashti A, Hern\u00e1ndez-Castro C, et al. Prevalence and public health relevance of enteric parasites in domestic dogs and cats in the region of Madrid (Spain) with an emphasis on Giardia duodenalis and Cryptosporidium sp. Vet Med Sci. 2023;9:2542\u201358.","journal-title":"Vet Med Sci"},{"key":"6797_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crpvbd.2023.100158","volume":"4","author":"AD Barbosa","year":"2023","unstructured":"Barbosa AD, Egan S, Feng Y, Xiao L, Ryan U. Cryptosporidium and Giardia in cats and dogs: What is the real zoonotic risk? Curr Res Parasitol Vector-Borne Dis. 2023;4:100158.","journal-title":"Curr Res Parasitol Vector-Borne Dis"},{"key":"6797_CR7","unstructured":"ESCCAP guideline 06, Control of intestinal protozoa in dogs and cats, Second Edition, 2018"},{"key":"6797_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","volume":"14","author":"TB Gardner","year":"2001","unstructured":"Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. 2001;14:114\u201328.","journal-title":"Clin Microbiol Rev"},{"key":"6797_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","volume":"43","author":"J Samuelson","year":"1999","unstructured":"Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother. 1999;43:1533\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"6797_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vetpar.2014.02.050","volume":"204","author":"T Geurden","year":"2014","unstructured":"Geurden T, Olson ME. World Association for the Advancement of Veterinary Parasitology (WAAVP): Guideline for the evaluation of drug efficacy against non-coccidial gastrointestinal protozoa in livestock and companion animals. Vet Parasitol. 2014;204:81\u20136.","journal-title":"Vet Parasitol"},{"key":"6797_CR11","first-page":"100768","volume":"34","author":"EM Eppler","year":"2022","unstructured":"Eppler EM, Hanzlicek G, Londono-Renteria B, Jesudoss Chelladurai JRJ. Survey of U.S. based veterinarians\u2019 knowledge, perceptions and practices about canine giardiasis. Vet Parasitol. 2022;34:100768.","journal-title":"Vet Parasitol"},{"key":"6797_CR12","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1128\/jcm.31.11.2944-2946.1993","volume":"31","author":"L Xiao","year":"1993","unstructured":"Xiao L, Herd RP. Quantitation of Giardia cysts and Cryptosporidium oocysts in fecal samples by direct immunofluorescence assay. J Clin Microbiol. 1993;31:2944\u20136.","journal-title":"J Clin Microbiol"},{"key":"6797_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13071-018-2990-6","volume":"11","author":"JM Barbecho","year":"2018","unstructured":"Barbecho JM, Bowman DD, Liotta JL. Comparative performance of reference laboratory tests and in-clinic tests for Giardia in canine feces. Parasit Vectors. 2018;11:444.","journal-title":"Parasit Vectors"},{"key":"6797_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/j.tcam.2010.07.003","volume":"25","author":"S Tanstrongsup","year":"2010","unstructured":"Tanstrongsup S, Scorza V. Update on the diagnosis and management of Giardia spp infections in dogs and cats. Top Compan Animal Med. 2010;25:155\u201362.","journal-title":"Top Compan Animal Med"},{"key":"6797_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4314\/jpb.v16i2.4","volume":"16","author":"AO Shittu","year":"2019","unstructured":"Shittu AO, Njinga NS, Olatinwo S, Afosi AB. Design and characterization of taste masked metronidazole microcapsules and its utilization in the formulation of orodispersible tablets. J Pharm Bioresourc. 2019;16:112\u201324.","journal-title":"J Pharm Bioresourc"},{"key":"6797_CR16","first-page":"110","volume":"16","author":"L Faure","year":"2018","unstructured":"Faure L, Fournel S, Nicolas C, Rigaut D. A field clinical study to confirm the efficacy and safety of a metronidazole- based oral suspension in dogs naturally infested by Giardiasis: comparison to fenbendazole. Intern J Appl Res Vet Med. 2018;16:110\u20136.","journal-title":"Intern J Appl Res Vet Med"},{"key":"6797_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vetpar.2011.12.023","volume":"187","author":"R Fiechter","year":"2012","unstructured":"Fiechter R, Deplazes P, Schnyder M. Control of Giardia infections with ronidazole and intensive hygiene management in a dog kennel. Vet Parasitol. 2012;187:93\u20138.","journal-title":"Vet Parasitol"},{"key":"6797_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.rvsc.2023.04.022","volume":"159","author":"F Romano","year":"2023","unstructured":"Romano F, Lallo MA. Efficacy of a single dose of nitazoxanide in dogs naturally infected with Giardia duodenalis. Res Vet Sci. 2023;159:252\u20136.","journal-title":"Res Vet Sci"},{"key":"6797_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exppara.2009.07.005","volume":"124","author":"JF Rossignol","year":"2010","unstructured":"Rossignol JF. Cryptosporidium and Giardia: Treatment options and prospects for new drugs. Exp Parasitol. 2010;124:45\u201353.","journal-title":"Exp Parasitol"},{"key":"6797_CR20","unstructured":"Decock C, Cadiergues MC, Roques M, Franc M, Evaluation of four treatments of canine giardiasis, Revue Med Vet, 154, 763\u2013766"},{"key":"6797_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4314\/ovj.v10i1.12","volume":"10","author":"S Perrucci","year":"2020","unstructured":"Perrucci S, Berrilli F, Procopio C. Giardia duodenalis infection in dogs affected by primary chronic enteropathy. Open Vet J. 2020;10:74\u20139.","journal-title":"Open Vet J"},{"key":"6797_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.vetpar.2017.07.030","volume":"244","author":"FD Uehlinger","year":"2017","unstructured":"Uehlinger FD, Naqvi SA, Greenwood SJ, McClure JT, Conboy G, O\u2019Handley R, Barkema HW, Comparison of five diagnosis tests for Giardia duodenalis in fecal samples from young dogs. Vet Parasitol. 2017;244:91\u20136.","journal-title":"Vet Parasitol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06797-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:39:49Z","timestamp":1747039189000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6797"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06797-w","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Virbac\u2019s animal ethics committee according to Directive 2010\/63\/EU and the United States authorities\u2019 requirements. Participation in this clinical trial was voluntary. Owners were fully informed about the trial's content and their rights. Signed informed consent was obtained from each dog owner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors were employed by Virbac.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}